Dynamic Advisor Solutions’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Other funds holding GALT
WANY
GWM
Dynamic Advisor Solutions's GALT Position: Q3 2025 in Review
Dynamic Advisor Solutions sold out of Galectin Therapeutics (GALT) in Q3 2025, closing a stake of 10,000 shares — an estimated $21.1K sold.
Dynamic Advisor Solutions first reported a position in GALT in Q2 2017 and held it in 33 quarters. The position peaked at $64K in Q2 2018. 84 funds tracked by Wall St. Rank hold GALT as of Q3 2025.
- Dynamic Advisor Solutions reported no remaining Galectin Therapeutics position as of Q3 2025 after selling out during the quarter.
- Dynamic Advisor Solutions sold 10,000 Galectin Therapeutics shares in Q3 2025, an estimated $21.1K.
- Dynamic Advisor Solutions first reported a position in Galectin Therapeutics in Q2 2017 and held it in 33 quarters.
- Dynamic Advisor Solutions's Galectin Therapeutics position peaked at $64K in Q2 2018.
- 84 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q3 2025.
Based on Dynamic Advisor Solutions's 13F filing for Q3 2025, filed 9 Oct 2025.